Nanoparticle compositions

Details for Australian Patent Application No. 2009336723 (hide)

Owner Novartis AG

Inventors Kissel, Thomas; Petersen, Holger; Renette, Thomas; Seidel, Nina

Agent Davies Collison Cave

Pub. Number AU-A-2009336723

PCT Pub. Number WO2010/079052

Priority 61/122,464 15.12.08 US

Filing date 14 December 2009

Wipo publication date 15 July 2010

International Classifications

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61B 5/00 (2006.01) Measuring for diagnostic purposes

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/079052 Priority application(s): WO2010/079052

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009336729-Methods for conducting cellular assays

2009336718-Octreotide depot formulation with constantly high exposure levels